• LAST PRICE
    0.6950
  • TODAY'S CHANGE (%)
    Trending Down-0.0248 (-3.4454%)
  • Bid / Lots
    0.6900/ 2
  • Ask / Lots
    0.7000/ 6
  • Open / Previous Close
    0.7150 / 0.7198
  • Day Range
    Low 0.6855
    High 0.7150
  • 52 Week Range
    Low 0.3611
    High 11.4450
  • Volume
    7,425
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.7198
TimeVolumeNBY
09:32 ET21130.7001
09:39 ET6000.701
09:44 ET2000.7086
09:48 ET4000.702922
09:50 ET1000.7001
09:57 ET2910.7002
10:00 ET3200.7
10:06 ET10000.691099
10:08 ET3000.6901
10:13 ET10280.6855
10:26 ET1000.69
10:31 ET2420.695
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNBY
NovaBay Pharmaceuticals Inc
3.5M
0.0x
---
United StatesCVSI
CV Sciences Inc
8.2M
-2.6x
-25.43%
United StatesSNOA
Sonoma Pharmaceuticals Inc
3.9M
-0.6x
---
United StatesEVFM
Evofem Biosciences Inc
1.0M
0.0x
---
United StatesGSRX
GSRX Industries Inc
80.0
0.0x
---
United StatesCPHI
China Pharma Holdings Inc
3.4M
-0.5x
---
As of 2024-11-22

Company Information

NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. It offers a portfolio of products for each step of the standard at home treatment regimen, including the Avenova Eye Health Support antioxidant-rich oral supplement, Avenova Lubricating Eye Drops for instant relief, NovaWipes by Avenova, Avenova Warm Eye Compress to soothe the eyes, and the i-Chek by Avenova to monitor physical eyelid health. It also manufactures and sells its proprietary form of hypochlorous acid for the wound care market with its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries.

Contact Information

Headquarters
2000 Powell St Ste 1150EMERYVILLE, CA, United States 94608-1804
Phone
510-899-8800
Fax
510-225-0371

Executives

Independent Chairman of the Board
Paul Freiman
Chief Executive Officer, Chief Compliance Officer, General Counsel
Justin Hall
Interim Chief Financial Officer, Treasurer
Tommy Law
Director
Mijia Wu
Director
Yongxiang Zheng

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.5M
Revenue (TTM)
$11.2M
Shares Outstanding
4.9M
NovaBay Pharmaceuticals Inc does not pay a dividend.
Beta
0.73
EPS
$-53.22
Book Value
$10.33
P/E Ratio
0.0x
Price/Sales (TTM)
0.3
Price/Cash Flow (TTM)
---
Operating Margin
-71.02%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.